Abstract-Multiple sclerosis (MS) patients are three to six times more likely to develop epilepsy compared to the rest of the population. Seizures are more common in patients with early onset or progressive forms of the disease and prognosticate rapid progression to disability and death. Gray matter atrophy, hippocampal lesions, interneuron loss, and elevated juxtacortical lesion burden have been identified in MS patients with seizures; however, translational studies aimed at elucidating the pathophysiological processes underlying MS epileptogenesis are limited. Here, we report that cuprizone-mediated chronically demyelinated (9-12 weeks) mice exhibit marked changes to dorsal hippocampal electroencephalography (EEG) and evidence of overt seizure activity. Immunohistochemical (IHC) analyses within the hippocampal CA1 region revealed extensive demyelination, loss of parvalbumin (PV + ) interneurons, widespread gliosis, and changes in aquaporin-4 (AQP4) expression. Our results suggest that chronically demyelinated mice are a valuable model with which we may begin to understand the mechanisms underlying demyelinationinduced seizures. Ó
INTRODUCTION
Multiple sclerosis (MS) is an autoimmune demyelinating disorder of the central nervous system (CNS) that affects roughly 2.3 million people worldwide (Browne et al., 2014) . In the United States, MS prevalence is estimated at 40-177 people per 100,000 (Evans et al., 2013) and varies with sex, ethnicity, and distance from the equator (Ropper et al., 2014) . While MS clinical presentation is multifarious, epidemiological studies show that MS patients are three to six times more likely to develop epileptic seizures than the overall population, with incidence rising with MS duration (Engelsen and Grønning, 1997; Poser and Brinar, 2003; Lund et al., 2014; Marrie et al., 2015) . Seizures in MS may signal disease onset or relapse in a subset of patients (Allen et al., 2013; Uribe-San-Martin et al., 2014) and are associated with diminished cognitive function (Calabrese et al., 2012) , fulminant disease course, and accelerated time to disability (Martinez-Juarez et al., 2009; Nicholas et al., 2016) . However, despite the increased occurrence of seizures among MS patients, little research exists probing their pathogenesis.
Electroencephalography (EEG) recordings from MS patients have revealed aberrant low-amplitude cortical alpha waves and the appearance of delta waves in awake patients (Babiloni et al., 2016) , while MS with seizures (MS + S) patients also exhibit waking theta frequencies and paroxysmal discharges (Ghezzi et al., 1990) . Magnetic resonance imaging (MRI) of MS + S patients demonstrates abundant temporal leukocortical lesions and hippocampal accumulation of demyelinating foci (Kutzelnigg et al., 2005; Martinez-Lapiscina et al., 2013; Cawley et al., 2015; Calabrese et al., 2016) in addition to findings common in MS, such as global cortical thinning and ventricular hypertrophy (Zivadinov et al., 2016) .
Examining postmortem MS + S entorhinal cortex, Nicholas et al. reported augmented middle temporal gyrus thinning relative to other cortical regions and layer IV & VI GABAergic interneuron loss not explained by leukocyte infiltration or mitochondrial dysfunction (Nicholas et al., 2016) . This is analogous to findings from epileptic hippocampi, which show loss of pyramidal neurons and GABAergic interneurons throughout the hippocampal formation (de Lanerolle et al., 2012; Huusko et al., 2015) . Interestingly, MS + S cortical atrophy and neuron loss is localized to structures associated with mesial temporal lobe epilepsy (MTLE) (Calabrese et al., 2012; Nicholas et al., 2016) seema.tiwari-woodruff@medsch.ucr.edu, seema-tiwari-woodruff@axonremyelination.org (S. K. Tiwari-Woodruff).
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Neuroscience 346 (2017) [409] [410] [411] [412] [413] [414] [415] [416] [417] [418] [419] [420] [421] [422] the development of seizures secondary to MS has been probed by a limited number of EEG, MRI, and postmortem histological studies, little is known regarding its etiology or neuropathology. Furthermore, translational research examining this phenomenon and its origins is restricted to a single study (Hoffmann et al., 2008) .
Although several well-established mouse models of MS are available (Merrill, 2009; McCarthy et al., 2012) , the cuprizone (bis-cyclohexanone-oxalyldihydrazone; CPZ) diet model was utilized by this study to probe seizures secondary to demyelination. CPZ symptomology is highly reproducible and mirrors clinical features of progressive MS (Lucchinetti et al., 2000; Matsushima and Morell, 2006; Praet et al., 2014) . CPZ neuropathology includes axon damage (Kim et al., 2010; ManriqueHoyos et al., 2012) , mitochondrial stress (Praet et al., 2014; Mahad et al., 2015) , motor deficits primarily relegated to gait ataxias (Franco-Pons et al., 2007) , and easily identifiable tonic-clonic seizures (Hoffmann et al., 2008; Praet et al., 2014) . Early reports examining CPZ intoxication noted convulsions in Swiss mice fed P0.3% CPZ for P7 weeks, but did not investigate their pathogenesis Carlton, 1970, 1983) . To our knowledge, only one group has characterized seizures induced by the lower 0.2% concentration of CPZ currently used to model MS (Hoffmann et al., 2008) . This group observed unusual spiking in cortical EEG recordings from chronically (P9 weeks) CPZ demyelinated C57BL/6 mice and hippocampal neuron degeneration, but did not identify vulnerable populations or address glial involvement.
To elucidate specific cellular involvement, our group examined CA1 electrophysiology and histopathology in mice subjected to chronic CPZ-induced demyelination. The hippocampal formation frequently exhibits profound changes in MS (Geurts et al., 2007) and MTLE, and has been implicated as a focus of seizure initiation (de Lanerolle et al., 2012) and maintenance (Ellender et al., 2014; Toyoda et al., 2015) . These changes include loss of inhibitory interneuron populations, degeneration of CA1 principal neurons, and derangement of dentate gyrus projections into CA regions (de Lanerolle et al., 2012; Liu et al., 2014) . For these reasons, we probed CA1 neuronal pathology, including parvalbumin (PV) + inhibitory interneurons due to this population's vulnerability in demyelination and seizure models (Schwaller et al., 2004; Rossi et al., 2012; Liu et al., 2014) .
Glial changes were also assessed, since CPZ induces astrogliosis and phagocyte infiltration at intervals shorter than the chronic model utilized in the present study (Norkute et al., 2009; Skripuletz et al., 2013; Gudi et al., 2014; Praet et al., 2014; Clarner et al., 2015) . In addition, both human postmortem tissue and animal models of seizure show reactive astrocytes, which exhibit increased expression of the intermediate filament glial fibrillary acidic protein (GFAP) expression and alterations to channel proteins, including the water channel aquaporin-4 (AQP4) and the inward rectifier potassium channel Kir4.1, both of which are central to epileptogenesis (Oberheim et al., 2008; Anderson and Rodriguez, 2011; Binder et al., 2012; de Lanerolle et al., 2012 ; RodriguezCruces and Concha, 2015; Nwaobi et al., 2016) .
In this study, we characterized EEG waveforms recorded from within the dorsal hippocampus of chronically demyelinated mice with seizures. Our findings indicate that theta and beta frequency power differs with duration of CPZ administration. Additionally, we describe CA1 neuronal and glial histopathology, including infiltration of microglia/macrophages, astrogliosis, changes to AQP4 expression with CPZ duration, pyramidal layer atrophy, and loss of PV + interneurons. These results lay a solid foundation for the study of seizure development secondary to demyelination and highlight the necessity for additional research into the pathogenesis of this phenomenon.
EXPERIMENTAL PROCEDURES Animals
B6.Cg-Tg(Thy1-YFP)16Jrs/J mice backcrossed to wildtype C57BL/6 mice for more than five generations (hereafter referred to as Thy1-YFP mice) were obtained from the Jackson Laboratory (Bar Harbor, ME) and maintained at the University of California Riverside (UCR) animal facility. Originally described by Feng et al. (2000) , Thy1-YFP mice express yellow fluorescent protein (YFP) under the control of modified mouse Thy1 regulatory elements at high levels, resulting in YFP expression in axons, dendrites, and soma of sensory, motor, and some central neurons with no detectable expression in other cell types. Thy1-YFP mice are healthy and have no distinguishable phenotype aside from neuronal YFP expression. All procedures and experiments were conducted in accordance with the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals and approved by the Institutional Animal Care and Use Committee at UCR.
Cuprizone treatment
Eight-week-old male Thy1-YFP mice were assigned to groups that received standard chow (normal; n = 10) or 0.2% cuprizone (CPZ)-milled chow (Harlan Teklad, Madison, WI) as detailed in Crawford et al. (Crawford et al., 2009 ) for 9 or 12 weeks-hereafter referred to as 9-wk CPZ (n = 10) and 12-wk CPZ (n = 9), respectively. Normal mice received standard chow (Picolab, St. Louis, MO) following the same timeline. All groups had access to food and water ad libidum and were housed on a 12-h light/dark cycle under pathogen-free conditions at the UCR animal facility.
EEG probe preparation
A 3-channel twisted bipolar stainless steel electrode was used for all EEG experiments (Plastics One, Roanoke, VA). The bipolar wires were cut to 2 mm in length for intrahippocampal recordings. Similarly, an epidural ground electrode was cut to 0.5 mm and placed during stereotactic surgery (Paxinos and Franklin, 2004) . Approximately 0.5 mm of the insulating coat was removed at the distal tip of the bipolar recording electrode using a scalpel to ensure high-fidelity EEG recordings. Implants were sterilized with 70% ethanol and the ground position on top of the implant pedestal was marked to ensure proper placement of the pins during data acquisition prior to insertion.
EEG implantation
Unilateral indwelling EEG electrodes were chronically implanted in the right dorsal hippocampus after 8 weeks of CPZ or control chow for longitudinal recordings as detailed in . Mice were anesthetized by intraperitoneal injection of 80 mg/kg ketamine (Phoenix Pharmaceuticals, Burlingame, CA) and 10 mg/kg xylazine (Akorn Inc., Lake Forest, IL). Anesthesia was continuously monitored by testing hind limb paw pinch reflex and additional anesthetics were administered as needed. Body temperature was maintained at 37°C using a homeothermic pad. Scalp hair was removed using clippers and depilatory cream (Nair; Church Dwight Company, Inc., Trenton, NJ), then disinfected with betadine solution (Purdue Products, Stamford, CT) and cleaned with 70% ethanol.
Mice were immobilized within a stereotaxic frame (Stoelting, Wood Dale, IL) and a midline incision was made and reflected to expose the skull, which was then cleaned with sterile saline and cotton swabs. Etching gel (Kuraray America, New York, NY) was applied to the skull for 10 s, then washed 2-3 times with sterile saline.
EEG electrodes were implanted 1.8 mm caudal and 1.6 mm lateral to bregma to position probe at the right dorsal hippocampus. A 2 mm diameter craniotomy was performed to accommodate the distance between the recording and ground wires using a high-speed surgical hand drill (Foredom, Bethel, CT) equipped with a 1/4-HP-sized carbide bur (SS White, Lakewood, NJ). The skull was cleaned again with sterile saline and the dura was carefully removed using a 27G needle to prevent laceration of the pia or underlying cortex. Bonding agent (Clearfil photo bond; Kuraray America) was prepared according manufacturer instructions and carefully applied on the skull by microbrush to avoid the brain, then cured until completely set. The EEG implant was then secured onto a probe holder with a side clamp and lowered into the hippocampus until the implant pedestal contacted the top of the skull (2 mm per the length of the probe). After verifying that the implant was in place, permanent cement (Panavia SA Cement; Kuraray America) was applied caudal to the implant and skull, then light cured until set. The side clamp was carefully released and the probe holder was raised. Remaining cement was applied in even layers to the exposed skull and the margins of the scalp to ensure a strong hold.
Video-EEG recordings
Treatment groups were separated into two subgroups for staggered video-EEG (vEEG) recordings, which were obtained at weeks 9 and 12 for 4 h per day. Animals 1-3 were recorded on Days 1 and 3, and animals 4-5 were recorded on Days 2 and 4. Control animals were recorded one week after probe implantation. Animals were connected to a tethered EEG recording system via a commutator (Plastics One) connected to a digital EEG acquisition system (MP150, AcqKnowledge 4.4 software) to allow them freedom of motion during data acquisition. Normal EEG output was filtered at 35 Hz (low pass) and 0.1 Hz (high pass) at a gain of 20,000 with a sample rate of 5,000 samples/s. Behavioral activity was recorded using a Sony FDR-AX33 digital video camera (New York, NY) placed in front of the animals' home cages capable of infrared dark phase recording.
EEG analysis
Mice that had no EEG signal due to poor contact of electrodes resulting from chronic recording were excluded from analysis. One mouse was excluded from the normal group (final n = 9) and 3 mice were excluded from the 9 week demyelinated group (final n = 7). No mice were excluded from the 12-wk CPZ group (n = 10). Resting EEG data were analyzed using BrainVision Analyzer 2.1 (Brain Products GmbH, Gilching, Germany). Mice were recorded for 4 h and the entire recording period was analyzed to avoid bias. Artifacts were removed with semi-automatic procedure in BrainVision Analyzer 2.1 software based on gradient, max-min, and low-activity criteria. Resting EEG signals were divided into 1 s segments and Fast Fourier Transform (FFT) was performed on each segment at 1 Hz resolution from 1 to 29 Hz to generate frequency values for each animal in the groups analyzed. Predetermined frequency ranges [Delta (1-4 Hz), Theta (4-7 Hz), Alpha (7-15 Hz), and Beta (15-29 Hz)] were compared by a one-way ANOVA with Tukey's posttest for multiple comparisons.
IHC
After concluding EEG recordings, all mice, regardless of EEG contact strength (Normal n = 10, 9-wk CPZ n = 10, 12-wk CPZ n = 9), were perfusion fixed and processed for IHC (Moore et al., 2014) . Briefly, mice were deeply anesthetized by isoflurane inhalation (Piramal Healthcare, Mumbai, India) and perfused transcardially with cold phosphate-buffered saline (PBS, Thermo Fisher Scientific, Waltham, MA) then 10% formalin (Thermo Fisher Scientific). Brains were dissected and post-fixed in 10% formalin (Thermo Fisher Scientific) for 24 h, cryoprotected in 30% sucrose (EMD Millipore, Darmstadt, Germany) for 48 h, and embedded in gelatin for sectioning. 40-lm coronal sections were cut using a HM525 NX cryostat (Thermo Scientific). Sections containing rostral corpus callosum (CC) or dorsal hippocampus were stained by IHC following a previously described protocol (Tiwari-Woodruff et al., 2007; Mangiardi et al., 2011) .
Myelination, gliosis, and CA1 pyramidal cell layer neuron densities were visualized by the following primary antibodies at a concentration of 1:500 in PBS unless otherwise noted: chicken anti-myelin basic protein (MBP; polyclonal, EMD Millipore), rabbit antiolig2 (polyclonal, Thermo Fisher Scientific), mouse anticleaved caspase 3 (1:400, clone AM1.31-11, EMD Millipore), mouse anti-glial fibrillary acidic protein (GFAP; clone 1B4, BD Biosciences, San Diego, CA), rabbit anti-aquaporin 4 (AQP4; polyclonal, EMD Millipore), mouse anti-NeuN (clone A60, EMD Millipore), mouse anti-parvalbumin (PV; 1:400, clone PARV-19, EMD Millipore), mouse anti-adenomatous polyposis coli (CC-1; clone CC-1, Genetex, Irvine, CA), rabbit anti-Ki-67 (1:250, polyclonal, EMD Millipore), and guinea pig anti-doublecortin (DCX; polyclonal, EMD Millipore).
Secondary staining was performed using these polyclonal fluorophore-conjugated antibodies from ThermoFisher Scientific diluted 1:500 unless otherwise noted: goat anti-rabbit IgG (H+L) Cy3 (EMD Millipore), goat anti-mouse IgG (H+L) Alexa FluorÒ647 (AF647), goat anti-mouse IgG2a AF647, rabbit anti-goat IgG (H +L) AF647, goat anti-rabbit (H+L) AF647, goat antimouse IgG2b AF647, goat anti-guinea pig IgG (EMD Millipore), and donkey anti-chicken IgY Cy3 (EMD Millipore). Nuclei were stained with 4 0 ,6-diamidino-2-phe nylindole (DAPI, 2 ng/ml; Molecular Probes) for 15 min after incubation with secondary antibodies and sections were mounted onto positively charged glass slides, allowed to dry, and coverslipped using Fluoromount G mounting medium (Thermo Fisher Scientific).
Confocal microscopy and analysis
CC and hippocampal CA1 contralateral to probe were imaged using an Olympus BX61 confocal microscope (Olympus America Inc., Center Valley, PA) at 10Â or 40Â magnification. 620 lm thick z-stack projections were compiled using SlideBook 6 software (Intelligent Imaging Innovations, Inc., Denver, CO). Whole coronal section images were acquired at 10Â magnification and stitched with Olympus cellSens Software (Olympus America Inc.). Immunostaining was quantified using Fiji version 2.2.0-rc-46/1.50 g (NIH). One data point per stain per animal was entered for each brain region analyzed. To avoid experimenter bias, auto-adjustment of brightness and contrast, as well as threshold of staining signal, was carried out by NIH software. NeuN
+ , CC-1 + , Thy1-YFP + blebs, and Ki-67 + cells were quantified by drawing a region of interest (ROI) around a brain structure to be analyzed (CC, CA1 subfields), measuring the area delineated by the ROI, counting immunoreactive cells within the ROI, then counts were normalized to area measured. GFAP, MBP, and DCX immunoreactive signal intensity was determined by Fiji and normalized to area of ROI. Iba1, AQP4, and MBP + % area was measured as percent positive immunoreactivity within ROIs.
Statistical analysis
Statistical analysis was carried out per previously published work (Tiwari-Woodruff et al., 2007; Crawford et al., 2010) . All statistics were performed using Prism 6 software (GraphPad Software, La Jolla, CA). Differences were considered significant at p 6 0.05. P values are represented by the following: * p 6 0.05, ** p 6 0.01, *** p 6 0.001, **** p 6 0.0001. Effect size (g 2 ) is reported as the fraction of the overall variance of all groups pooled attributable to differences among the group means. EEG and IHC data are presented as mean ± SEM and were analyzed by an ordinary one-way ANOVA with Tukey's posttest for multiple comparison test to generate pvalues. Number of animals in each group ranged from 7 to 10/group for EEG analysis and 8-12/group for IHC analysis.
RESULTS
Chronic cuprizone demyelination induces behavioral seizures and changes to hippocampal EEG Thy1-YFP mice fed CPZ for 9 weeks (9-wk CPZ) and 12 weeks (12-wk CPZ) appeared somewhat more active when undisturbed in their home cages relative to standard diet-fed control (normal) mice, but activity level was not quantified. Overall, non-seizure behavioral changes between groups were minimal and have been described previously (Franco-Pons et al., 2007; Praet et al., 2014) . Overt seizure-like behavior (Fig. 1A Seizure) was observed during handling in approximately 30.0% of 8-wk CPZ mice. Seizure behavior increased to 57.5% in 9-wk CPZ mice and 66.25% in 12-wk CPZ mice (n = 20-45 total mice observed over four separate experiments, Fig. 1B ). Spontaneous seizures were also recorded in mice unperturbed in their home cages during both light and dark cycles by vEEG (Supplemental Video 1).
Verification and characterization of seizure waveforms in chronically demyelinated mice were performed by intrahippocampal EEG recording. The dorsal hippocampus was selected as the site of electrode implant based on its role in seizure initiation and maintenance (de Lanerolle et al., 2012; Ellender et al., 2014; Toyoda et al., 2015) . One week after electrodes were placed, resting state EEG waveforms were acquired to determine if electrical signals corresponded with behavior observed. Mice were awake and freely moving during vEEG recordings (Fig. 1A -EEG Setup).
Significant changes in EEG power were observed with chronic demyelination (Fig. 1 C, D) . 9-wk CPZ mice (n = 7) displayed suppressed EEG waveform power compared to normal mice (n = 9), but 12-wk CPZ group (n = 10) waveform power was equivalent to normal (Fig. 1C, D) . Theta, alpha, and beta frequencies were significantly increased in 12-wk CPZ mice compared to 9-wk CPZ mice and delta power also trended toward an increase ( Fig. 1E ; delta p = 0.0573, g 2 = 0.2320; theta * p 6 0.05, g 2 = 0.2928; alpha * p 6 0.05 g 2 = 0.2571; beta * p 6 0.05 g 2 = 0.3203). EEG data were analyzed by one-way ANOVA with Tukey's posttest for multiple comparisons.
Demyelination occurs in the CC and hippocampus of chronically cuprizone-fed mice CPZ causes demyelination throughout the CNS by induction of apoptotic pathways in post-mitotic oligodendrocytes (OLs) secondary to mitochondrial dysfunction and accumulation of reactive oxygen species (Mahad et al., 2008; Praet et al., 2014) . Montages of coronal brain slices immunostained for myelin basic protein (MBP, green) with nuclei counterstained by 4 0 ,6-diamidino-2-phenylindole (DAPI, red) from normal, 9-wk CPZ and 12-wk CPZ mice showed extensive demyelina-tion in the corpus callosum (CC), cortical hemispheres, and dorsal hippocampus (Hip) (Fig. 2A) . A detailed analysis of CC (Fig. 2Bi) and CA1 stratum radiatum (SR) and stratum lacunosum moleculare (SLM) subregions contralateral to EEG implant (Fig. 2Bii) revealed decreased myelin density in the CC ( Fig. 2C ; 9-wk CPZ vs normal ** p 6 0.01; 12-wk CPZ vs normal ** p 6 0.01, g 2 = 0.4373) and CA1 SR/SLM subregions ( Fig. 2G ; 9-wk CPZ vs normal **** p < 0.0001, 12-wk CPZ vs normal **** p < 0.0001, g 2 = 0.7453) of CPZfed groups.
To investigate the status of OLs in the CNS after chronic demyelination, brain sections were immunostained for the OL lineage-specific transcription factor Olig2 (Meijer et al., 2012) . No difference was observed in Olig2 + OL numbers in the CC of any group (Fig. 2Bi, D) . Olig2 + OLs were significantly decreased in the CA1 of 12-wk CPZ compared to normal (Fig. 2Bii , H, * p 6 0.05, g 2 = 0.2725). Post-mitotic OLs were identified by positive immunostaining for both Olig2 and adenomatous polyposis coli (CC-1), a negative regulator of Wnt/b-catenin signaling in myelinating OLs in the CNS (Lang et al., 2013) . The number of Olig2 + -CC-1 + post-mitotic OLs were decreased by >75% in the CC of 9-wk and 12-wk CPZ groups (Fig. 2E, 9 wk CPZ vs normal **** p < 0.0001, 12-wk CPZ vs normal **** p < 0.0001, g 2 = 0.8933). Similarly, decreased Olig2 + CC-1 + OL numbers were observed in the CA1 of 9-wk and 12-wk CPZ mice relative to normal mice (Fig. 2Biv, I , 9-wk CPZ vs normal ** p 6 0.01, 12-wk CPZ vs normal **** p < 0.0001, g 2 = 0.5471). To assess the status of ongoing apoptosis in OLs due to CPZ, immunostaining for cleaved caspase 3 was performed. In the CC of 9-wk CPZ mice, 46.70 ± 1.784% of Olig2 + OLs exhibited cleaved caspase 3 staining, indicating that these cells were committed to apoptosis (Porter and Janicke, 1999) (Fig. 2F, 9 -wk CPZ vs normal **** p < 0.0001, g 2 = 0.9784). Similarly, apoptotic cells comprised 46.39 ± 1.661% of total Olig2 + OL lineage cells in the CC of 12-wk CPZ Fig. 1 . Hippocampal electroencephalogram (EEG) changes occur in chronically demyelinated mice. A) Representative images of a control mouse fed normal diet (normal), an experimental mouse fed cuprizone (CPZ) diet for nine weeks (9-wk CPZ) undergoing seizure-like behavior during handling (seizure), and a normal mouse with an intrahippocampal probe tethered to an external EEG recording setup to allow freedom of movement (EEG setup). B) Nearly 30% of mice on CPZ diet for 8 weeks displayed overt seizure during handling. Seizure activity increased to 55% in 9-wk CPZ mice and 65% in 12-wk CPZ mice (total of 20-45 mice observed over 3 different experiments). C) Representative 30-min recordings from a normal, 9-wk CPZ, & 12-wk CPZ animal. D) Recording period highlighted in blue box from A was magnified to better assess changes in activity. E) Frequency analysis was performed on 4 h of EEG recordings from the same period in normal [n = 9], 9-wk CPZ [n = 7], and 12-wk CPZ [n = 10] groups. No significant changes were observed in any frequency between normal and 9-wk CPZ groups. Similarly, 12-wk CPZ mice showed power equivalent to normal across all frequencies, but exhibited increased theta, alpha, and beta frequency power compared to 9-wk CPZ (theta 2 . Demyelination in the corpus callosum (CC) and hippocampus (Hip) during chronic cuprizone diet. A) Representative 10X magnification montages of coronal brain sections immunostained for myelin basic protein (MBP, green) and nuclei (DAPI, red) from normal, 9-wk CPZ, and 12-wk CPZ mice show decreased MBP staining in the CC and Hip of 9-wk and 12-wk CPZ mice. Scale bar: 1 mm, * indicates injury at the site of EEG probe implant. B) Representative 10X magnification image of CC, scale bar 100 lm (i) and 40X magnification image of Hip area showing the stratum radiatum (SR) and stratum lacunosum moleculare (SLM) (ii) immunostained for MBP (green) and DAPI (red). A decrease in myelinated fibers was observed in 9-wk and 12-wk CPZ mice. 40X magnification images of the CC (iii) and CA1 (iv) immunostained for Olig2 (green) and DAPI (red) were analyzed for Olig2 + oligodendrocyte (OL) lineage cell numbers. Scale bar in ii, iii, and iv is 10 lm. C) Quantification of MBP staining intensity in the CC normalized to area measured showed a significant decrease in 9-wk CPZ ( ** p 6 0.01) and 12-wk CPZ groups ( ** p 6 0.01) compared to normal mice (n = 8-10 animals/group, one-way ANOVA with Tukey's posttest for multiple comparisons, g 2 = 0.4373). D) No difference was identified in the number of Olig2 + nuclei counted in the CC of normal, 9-wk CPZ, and 12-wk CPZ mice (n = 7-10 animals/group, one-way ANOVA with Tukey's posttest for multiple comparisons). E) Fewer post-mitotic Olig2 + CC-1 + OLs were counted in the CC of 9-wk CPZ ( **** p < 0.0001) and 12-wk CPZ ( *** p < 0.0001) groups as compared to normal mice (n = 7-10 animals/group, one-way ANOVA with Tukey's posttest for multiple comparisons, g 2 = 0.8933). F) Apoptotic Olig2 + caspase 3 + cells accounted for 44.29 ± 2.879% of all Olig2 + OL lineage cells in the CC of 9-wk CPZ mice (9-wk CPZ vs normal **** p < 0.0001) and 46.39 ± 1.661% of total Olig2 + OL lineage cells in the CC of 12-wk CPZ mice (12-wk CPZ vs normal **** p < 0.0001). No difference was observed between 9-wk CPZ and 12-wk CPZ groups (n = 7-10 animals/group, one-way ANOVA with Tukey's posttest for multiple comparisons, g 2 = 0.9784). G) MBP immunostained areas of CA1 SR/SLM subregions were significantly reduced in 9-wk CPZ ( **** p < 0.0001) and 12-wk CPZ groups ( **** p < 0.0001) compared to normal mice (n = 8-10 animals/group, one-way ANOVA with Tukey's posttest for multiple comparisons, g 2 = 0.7453). H) No significant change was observed in Olig2 + OLs between normal and 9-wk CPZ mice, but a 20% decrease in Olig2 + OLs was observed in 12-wk CPZ compared to normal mice ( * p 6 0.05). (n = 8-10 animals/group, one-way ANOVA with Tukey's posttest for multiple comparisons, g 2 = 0.2725). I) Post-mitotic Olig2 + CC-1 + OLs counted in the CA1 were significantly decreased in 9-wk CPZ ( ** p 6 0.01) and 12-wk CPZ mice ( **** p < 0.0001) compared to normal (n = 9-10 animals/group, one-way ANOVA with Tukey's posttest for multiple comparisons, g 2 = 0.5471). J) Cleaved caspase 3-labeled Olig2 + OL lineage cells were not observed in any groups analyzed (n = 8-10 animals/group, one-way ANOVA with Tukey's posttest for multiple comparisons). mice (Fig. 2F, 12 -wk CPZ vs normal **** p < 0.0001, g 2 = 0.9784). Interestingly, although MBP reactivity and Olig2 + OL lineage cells were reduced in the CA1 of 9-wk and 12-wk CPZ mice, cleaved caspase 3 immunoreactivity was not observed in either group (Fig. 2J) , indicating that Olig2 + cell loss was caspase 3 independent. IHC data were analyzed by one-way ANOVA with Tukey's posttest for multiple comparisons.
Microglia/macrophage infiltration, astrogliosis, and dysregulation of AQP4 expression Microglia/macrophages expressing ionized calciumbinding adaptor molecule 1 (Iba1), a cytoplasmic protein constitutively expressed by macrophages and microglia (Ito et al., 1998) , occupied 10.44 ± 1.254% of imaged CA1 in normal mice and 13.26 ± 3.270% in 9-wk CPZ mice (Fig. 3C ). Iba1 + immunoreactive area increased more than threefold in the CA1 of 12-wk CPZ mice to 47.29 ± 10.98% of imaged fields (Fig. 3C , 12-wk CPZ vs normal ** p 6 0.01, 12-wk CPZ vs 9-wk CPZ ** p 6 0.01, g 2 = 0.5128). Upregulation of GFAP by reactive astrocytes occurs in the context of inflammatory demyelination and MTLE, confining damage and inflammatory mediators to the area behind the resulting glial scar (Domingues et al., 2016; Robel, 2016) . GFAP + cells in the CA1 of both 9-and 12-wk CPZ groups displayed hypertrophic morphology characteristic of reactive astrocytes, membrane varicosities, and loss of non-overlapping process domains (arrowheads). (Fig. 3B ), but these parameters were not quantified. The number of GFAP + astrocytes significantly increased in the CA1 of 9-wk CPZ ( *** p 6 0.001) and 12-wk CPZ ( *** p 6 0.001) groups compared to normal mice (Fig. 3D , g 2 = 0.5658). GFAP staining intensity per astrocyte increased in 12-wk CPZ mice compared to normal, indicating increased GFAP expression per cell in the chronically demyelinated CA1 (Fig. 3E , * p 6 0.05, g 2 = 0.2514). The astrocyte specific water channel AQP4 plays a crucial role in maintaining CNS water and ion homeostasis Nagelhus and Ottersen, 2013) . Perturbations in AQP4 expression and localization have been identified in postmortem sclerotic hippocampal tissue from epileptic donors (Lee et al., 2004 ) and translational models of epilepsy . In normal mice, AQP4 reactivity covered 8.628 ± 0.6162% of the imaged CA1 and followed vasculature (Fig. 3 B) . AQP4 immunoreactive area decreased to 4.281 ± 0.4782% in 9-wk CPZ mice, approximately 49% of normal controls ( ** p 6 0.01, g 2 = 0.5668), but recovered to 10.64 ± 1.297% in 12-wk CPZ mice (Fig. 3F, 12 -wk CPZ vs 9-wk CPZ **** p < 0.0001, g 2 = 0.5668). IHC data were analyzed by one-way ANOVA with Tukey's posttest for multiple comparisons.
Callosal axon damage, reduced pyramidal cell layer thickness, and loss of PV + interneurons in the CA1 of chronically demyelinated mice
To assess potential demyelination-induced axon damage, blebbing of axonal plasma membranes, which is associated with toxic protein accumulation (Lesort et al., 1997) , was analyzed in chronically demyelinated brain. The coherent linear morphology of Thy1-YFP + axons observed in the CC of normal mice was lost with chronic demyelination. Thy1-YFP + axon varicosities, indicative of transected axons or impaired axonal transport, were observed in 9-wk and 12-wk CPZ groups (Fig. 4A, arrowheads) . Quantification of axon blebs in the CC (Fig. 4E) showed a significant increase in 9-wk CPZ mice (9-wk CPZ vs normal **** p < 0.0001, g 2 = 0.9258) and 12-wk CPZ compared to normal mice (12-wk CPZ vs normal * p 6 0.05, g 2 = 0.9258). Blebbing in 9-wk CPZ mice was significantly higher compared to 12-wk CPZ mice (12-wk CPZ vs 9-wk CPZ **** p < 0.0001, g 2 = 0.9258), possibly reflecting loss of Thy1-YFP + axons in the latter time point. However, no axon or dendrite swelling/blebbing was observed in the SLM or SR of any group (Fig. 4B ). CA1 SO projection blebbing was not quantified due to its proximity to the CC, which made distinguishing the two fiber tracts problematic.
Degeneration of hippocampal pyramidal neurons is a feature commonly observed in sclerotic epileptic and MS hippocampi (Ziehn et al., 2010; de Lanerolle et al., 2012) . CA1 pyramidal cell layer thickness, measured as height of pyramidal layer nuclei reactive for NeuN, which labels a neuron-specific epitope found on the FOX-3 transcription factor (Mullen et al., 1992) , was significantly reduced in the brains of 12-wk CPZ mice relative to normal (Fig. 4C, F; * p 6 0.05, g 2 = 0.2458). However, total NeuN + pyramidal layer neurons did not change between groups (Fig. 4C, G) and did not co-localize with cleaved caspase 3 in any group examined (not shown), suggesting atrophy of neuronal cell bodies and/or dendrites.
Loss of parvalbumin (PV + ) inhibitory interneuron populations occurs in a variety of disease states, including experimental autoimmune encephalomyelitis (an autoimmune mouse model of MS), chemical/traumatic seizure induction, MTLE, and human MS lesions (Arabadzisz et al., 2005; Ziehn et al., 2010; Huusko et al., 2015; Nicholas et al., 2016) . PV is expressed by subset of GABAergic interneurons, including basket, axo-axonic, bistratified, and orienslacunosum molecular cells in the hippocampus (Schwaller et al., 2004; Liu et al., 2014) . Quantification of PV + inhibitory interneuron soma in the CA1 revealed a significant decrease in 12-wk CPZ mice compared to normal (Fig. 4D, H * p 6 0.05, g 2 = 0.4372). IHC data were analyzed by one-way ANOVA with Tukey's posttest for multiple comparisons.
The effect of chronic demyelination on neuronal regeneration was assessed by immunostaining for doublecortin (DCX), a microtubule associated protein expressed by newly generated neurons (Rao and Shetty, 2004) and Ki-67, a nuclear protein expressed by proliferating cells (Kee et al., 2002) . DCX + cells were not observed in the CA1 pyramidal cell layer of normal mice. However, DCX + cells with stellate morphology appeared in the CA1 SO and overlying white matter tract of 9-wk CPZ ( **** p < 0.0001) and 12-wk CPZ ( ** p 6 0.001) mice, but did not penetrate the pyramidal cell layer (Fig. 5A , B, g 2 = 0.6077). Ki-67 + nuclei were rarely observed in all groups analyzed and did not colocalize with DCX + cells. These data indicate that new neurons did not account for unchanged pyramidal cell numbers despite pyramidal layer thinning and reduced PV + staining during chronic demyelination.
DISCUSSION
Despite increased seizure incidence in MS patients (Evans et al., 2013) , little is known regarding the pathophysiology or risk factors that contribute to epileptogenesis in these patients. We have for the first time Fig. 3 . Macrophage/microglia infiltration, reactive astrocytes, and altered AQP4 expression are observed in the CA1 of chronically cuprizone-fed mice with seizures. A) Representative 40X magnification images of Iba1 (red)-and DAPI (blue)-immunostained CA1 stratum oriens (SO)/SR from normal, 9-wk CPZ, and 12-wk CPZ mouse coronal brain sections show increased Iba1 reactivity in 12-wk CPZ mice. Scale bar: 10 lm. B) Representative 40X magnification images of GFAP (green), AQP4 (red) immunostaining, and DAPI (blue) stained CA1 SO/SR of normal, 9-wk CPZ, and 12-wk CPZ mice. The number of GFAP + astrocytes and staining intensity per cell increased in the CA1 of 9-wk and 12-wk CPZ mice and displayed hypertrophic morphology characteristic of reactive astrocytes, membrane varicosities, and loss of non-overlapping process domains (arrowheads). In normal mice, AQP4 + staining followed vasculature and co-localized with GFAP at the site of astrocyte end foot processes contacting blood vessels. AQP4 staining decreased in 9-wk CPZ mice, but GFAP staining increased proximal to vasculature. AQP4 reactive area returned to normal levels in 12-wk CPZ mice and GFAP + reactive astrocytes did not accumulate near blood vessels. Scale bar: 10 lm. C) Iba1 + immunostaining in the CA1 was quantified as a percent of imaged field in normal, 9-wk CPZ, and 12-wk CPZ mice. Iba1 + microglia/macrophages occupied approximately 10-13% of the imaged CA1 in normal and 9-wk CPZ mice, but increased more than threefold in 12-wk CPZ mice to 47.29 ± 10.98% (12-wk CPZ vs normal, ** p 6 0.01; 12-wk CPZ vs 9-wk CPZ ** p 6 0.01; n = 7-9 animals/group, one-way ANOVA with Tukey's posttest for multiple comparisons, g 2 = 0.5128). D,E) Astrocytes were quantified by counting the number of GFAP + cells/area. A significant increase was observed in the CA1 of 9-wk CPZ ( *** p 6 0.001) and 12-wk CPZ (( *** p 6 0.001) groups compared to normal mice. GFAP staining intensity (represented in arbitrary units ''AU") per astrocyte also rose significantly in 12-wk CPZ mice compared to normal mice * p 6 0.05), indicating increased GFAP expression per cell (n = 8-10 animals/group, one-way ANOVA with Tukey's posttest for multiple comparisons; GFAP + cells/mm 2 g 2 = 0.5658; GFAP intensity per cell g 2 = 0.2514). F) AQP4 immunoreactive area was significantly decreased in the CA1 of 9-wk CPZ mice compared to normal ( ** p 6 0.01) and 12-wk CPZ groups ( **** p < 0.0001; n = 7-10 animals/group, one-way ANOVA with Tukey's posttest for multiple comparisons, g 2 = 0.5668).
demonstrated that long-term CPZ administration reproduces facets of neuropathology observed in human MS patients with seizures (Martinez-Lapiscina et al., 2013; Nicholas et al., 2016) . We observed changes in intrahippocampal EEG recordings from chronically demyelinated mice that experienced spontaneous seizures during chronic CPZ treatment. Specifically, we found a reduction in EEG power at the 9-week time point, which may reflect the electrophysiological effects of widespread cortical demyelination. Interestingly, we observed recovery of EEG power at the 12-week time point. Future studies will need to assess the timing of onset of spontaneous elec- + axon varicosities (arrowheads), indicative of transected axons or impaired protein transport, were observed in 9-wk and 12-wk CPZ groups. No axon or dendrite swelling/blebbing was observed in SR or SLM. Scale bar: 10 lm. C,D) Representative 40X magnification images of CA1 pyramidal layer immunostained for NeuN+ (green), DAPI, (blue), and parvalbumin (PV; red) from normal, 9-wk CPZ and 12-wk CPZ groups. A decrease in overall CA1 pyramidal neuron layer thickness and loss of PV + neurons was observed in 9-wk CPZ and 12-wk CPZ CA1 pyramidal layer. Scale bars: 10 lm. E) Quantification of axon blebs in the CC showed a significant increase in both 9-and 12-wk CPZ groups compared to the normal group (9-wk CPZ vs normal **** p < 0.0001; 12-wk CPZ vs normal * p 6 0.05). Blebbing in the CC of 9-wk CPZ mice was significantly higher than 12-wk CPZ mice ( **** p < 0.0001), reflecting fewer Thy1-YFP callosal axons (n = 8-10 animals/group, one-way ANOVA with Tukey's posttest for multiple comparisons, g 2 = 0.9258). F,G) Quantification of pyramidal cell layer thickness was determined by measuring the total height of NeuN + nuclei in the pyramidal cell layer. Compared to normal mice, a significant decrease was observed in pyramidal cell layer thickness of 12-wk CPZ mice ( * p 6 0.05). However, total pyramidal layer NeuN+ neurons were not statistically different between groups (n = 8-10 animals/group, one-way ANOVA with Tukey's posttest for multiple comparisons; pyramidal layer height g 2 = 0.2458). H) Quantification of PV + interneuron soma in the CA1 region pyramidal cell layer showed a significant decrease in 12-wk CPZ mice * p 6 0.05) as compared to normal group (n = 8-10 animals/group, one-way ANOVA with Tukey's posttest for multiple comparisons, g 2 = 0.4372).
trographic seizures in this model as well as the relationship of seizure onset to demyelination and other cellular and molecular changes. While the pathophysiology leading to seizures in chronic demyelination remains to be elucidated, our results indicate several possibilities. Loss of CA1 PV + interneuron cell bodies suggests impaired inhibition may contribute to seizures during demyelination. PV + inhibitory interneurons comprise an essential component of the hippocampal timing circuitry crucial to maintaining physiologic seizure resistance (Schwaller et al., 2004; Huusko et al., 2015; Wolf et al., 2016) . Our results mirror models of seizure disorders (Hernandez-Lain et al., 2013; Houser, 2014; Liu et al., 2014; Huusko et al., 2015) and autoimmune inflammatory demyelination (Ziehn et al., 2010) , where drop-out of PV + immunoreactivity is also observed. Future studies will examine whether CA1 inhibitory interneuron loss is confined to PV + cells or extends to other GABAergic populations, such as cholecystokinin octapeptide + cells which are thought to represent a distinct inhibitory network (Kohus et al., 2016) .
CPZ intoxication does not contribute to neuronal pathology directly (Praet et al., 2014) . Neuron sparing in the face of mitochondrial stress imposed by CPZ has been explained by metabolic coupling to astrocytes, which augment neuronal resilience by carrying out glycolysis in response to energetic deficits (Dewar et al., 2003; Marrif and Juurlink, 2003; Praet et al., 2014) . In addition to increased numbers of GFAP + reactive astrocytes, astrocytes displayed crossed domains, membrane blebbing, upregulation of GFAP, and altered AQP4 expression with chronic demyelination concurrent with changes to theta and beta frequency power and spontaneous seizure. Membrane blebbing of astrocyte processes has been shown to precede apoptotic cell death following oxygenglucose deprivation (Gouix et al., 2014) , and is associated with impaired ATP metabolism in other cell types (Lemasters et al., 1987) . However, whether blebbing observed reflects impaired metabolism or pre-apoptotic astrocytes requires additional investigation.
Recent research illustrates the importance of astrocyte-astrocyte and astrocyte-oligodendrocyte gap junction coupling in maintaining astrocyte homeostatic function and survival (Magnotti et al., 2011) . Genetic ablation of connexin-30 and connexin-43, two gap junction proteins responsible for oligodendrocyte-astrocyte coupling, leads to marked astrogliosis, myelin vacuolation, and tonic-clonic seizures (Magnotti et al., 2011) . While astrogliosis begins early with CPZ administration (Gudi et al., 2014) , in the chronically demyelinated CNS, loss of astrocyte-oligodendrocyte coupling via gap junctions could feasibly contribute to the seizures and pathological astrocyte morphology that our group observed. In addition, increased expression of the astrocyte gap junction + and doublecortin + cell populations in the CA1 of chronically demyelinated mice with seizures. A) Representative 40X magnification images of the CA1 pyramidal cell layer immunostained for doublecortin (DCX) and Ki-67 in normal, 9-wk CPZ, and 12-wk CPZ mice. DCX + cells with stellate morphology were observed in the CA1 SO and overlying white matter tract of 9-wk CPZ and 12-wk CPZ mice. Ki-67 + nuclei were rarely detected in the CA1 of any group and did not co-localize with DCX. Scale bar: 10 lm. B) DCX + cell numbers were significantly increased in the CA1 SO of 9-wk CPZ ( **** p < 0.0001) and 12-wk CPZ mice mice ( ** p 6 0.01; n = 8-9 animals/group, one-way ANOVA with Tukey's post test for multiple comparisons, g 2 = 0.6077). C) Ki-67 + nuclei numbers were not significantly different between groups (n = 8-9 animals/group, one-way ANOVA with Tukey's posttest for multiple comparisons).
protein connexin-43 and more rapid decay of inward glutamate currents in astrocytes have been shown to accompany kainic acid-induced seizures (Takahashi et al., 2010) . These changes occur prior to alteration of astrocyte inward potassium currents, indicating that changes in astrocyte coupling with other glia and glutamate buffering may herald the onset of spontaneous seizures in that model. Future studies will probe the extent to which changes in astrocyte-oligodendrocyte gap junctions are featured in the genesis of seizures in chronic CPZmediated demyelination and what consequences these changes may have on glutamate and potassium handling.
Mounting evidence suggests that downregulation of AQP4 is observed in seizure models and may play a role in hyperexcitability leading to seizures Alvestad et al., 2013; Hubbard et al., 2016) . Specifically, AQP4 appears to be downregulated during the epileptogenic period in which spontaneous seizures emerge Alvestad et al., 2013; Hubbard et al., 2016) . Our results showed a similar pattern, with a transient decrease in CA1 AQP4 expression at 9 weeks of demyelination at the earliest onset of observable seizures, then rising at 12 weeks once seizures were well established. Changes in aquaporin expression may be significant as their expression has been shown to trace Kir4.1 localization in astrocytes, implicating the co-involvement of these two molecules in regulating osmolarity that could contribute to perturbation of resting membrane potential and hyperexcitability by increasing extracellular potassium concentration. Additional study is necessary to identify whether alterations to Kir4.1/AQP4 homeostasis contribute to seizure genesis in chronic demyelination. In addition, chronic video-EEG monitoring will be needed to determine the exact time course of spontaneous seizure onset in the CPZ model and the focus of seizure initiation (hippocampus vs. cortex) (Hoffmann et al., 2008) .
The appearance of augmented Iba1 + immunoreactivity coinciding with seizures and changes to EEG theta and beta frequency power is congruous with findings from both translational models of epilepsy and analysis of postmortem human tissue (Zhang et al., 2016; Eyo et al., 2017) . Infiltration of microglia/-macrophages peaks at 4.5 weeks of CPZ intoxication as is mediated by the chemokines CCL2, CCL3, and CXCL10 (Clarner et al., 2015) . However, to the best of our knowledge, no studies have addressed microglia/macrophage behavior in the chronic CPZ model utilized in this study. In mouse models of epilepsy, microglia/macrophages express so-called M1 pro-inflammatory cytokines such as inducible nitric oxide synthase, tumor necrosis factor a, interleukin (IL)-1b, IL-6, and IL-12 as well as lymphocyte co-stimulatory molecules cluster of differentiation (CD) 80, CD86, and major histocompatibility complex II at high levels (Eyo et al., 2017) . M1 polarization may be attributable to signaling by TLR4/MYD88 and purinergic receptors, which play a prominent role in many neuroinflammatory states (Zhou et al., 2013; Hu and Mao, 2016) . Determining the phenotype of microglia/macrophages that appear in CA1 during chronic demyelination may help clarify their role in seizures secondary to MS.
Additional research is required to elucidate the pathophysiology underpinning inhibitory cell loss in chronic demyelination with seizures. However, based on our data, it is conceivable that chronic demyelinationinduced metabolic dysfunction arising in astrocytes due to oxidative stress or uncoupling from post-mitotic oligodendrocytes could preclude their ability to execute neuroprotective functions such as maintaining physiologic osmolarity and metabolite buffering, thereby leading to loss of vulnerable PV + neuron and seizures. The resulting release of ATP and inflammatory mediators from hippocampal neurons susceptible to excitotoxic death may then attract microglia/macrophages. Future studies will address the functional correlations of our results, while brain tissue from MS + S patients will be evaluated for markers observed in the present study to establish translational relevance.
Understanding the pathophysiology contributing to seizures in chronic demyelinating disease has implications extending beyond the treatment of MS with epilepsy. Oligodendrocyte death and dysmyelination are frequently noted features of seizure disorders. If a relationship exists between these phenomena and hippocampal GABAergic neuron survival, exposing this framework could inform investigation into novel therapeutic targets in epilepsy and MS that could prevent seizure-induced demyelination and/or demyelination-induced seizures.
